WELCOME TO THE

DELVE BLOG

Delve Health Provides the Technology Platform to Design Clinical Trials to Fit a Patient’s Lifestyle

—Not the Other Way Around
A significant number of companies announced delays and cancellations to planned and on-going clinical trials because of COVID-19 lockdowns and social distancing measures. There was a peak of 1,265 trials paused or indefinitely delayed in June 2020—impacting nearly 1,000 companies. Disruptions included delayed initiation or complete withdrawal of planned trials, as well as suspended enrollment or cancellation of on-going trials. The number of disrupted trials has been falling slowly since June 2020, with most current disruptions due to other factors, such as slow enrollment.

Mobile Strategy for Clinical Trials

Mobile technologies are gaining greater acceptance and adoption in clinical trials, to engage patients, investigators, and study team 90% of SMS are opened within 3

eConsent in Virtual Clinical Trial

Per the FDA guidance, an electronic consent is any “the use of electronic systems and processes that may employ multiple electronic media to obtain informed

Scroll to Top